Furthermore, studies suggest that TAMs can promote tumor progression by upregulating oncogenic MYC expression through activation of the STAT3 pathway in non-MYCN amplified neuroblastoma cells [72]. The gene discussed is STAT3; the disease is neuroblastoma.